Association between CLPTM1L polymorphisms (rs402710 and rs401681) and lung cancer susceptibility: evidence from 27 case–control studies
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association between CLPTM1L polymorphisms (rs402710 and rs401681) and lung cancer susceptibility: evidence from 27 case–control studies
Authors
Keywords
<em class=EmphasisTypeItalic >CLPTM1L</em>, 5p15.33, Polymorphism, Lung cancer, Meta-analysis
Journal
MOLECULAR GENETICS AND GENOMICS
Volume 289, Issue 5, Pages 1001-1012
Publisher
Springer Nature
Online
2014-06-06
DOI
10.1007/s00438-014-0868-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Replication Study in Chinese Population and Meta-Analysis Supports Association of the 5p15.33 Locus with Lung Cancer
- (2014) Juntao Ke et al. PLoS One
- Significant association of 5p15.33 (TERT–CLPTM1Lgenes) with lung cancer in Chinese Han population
- (2013) Zhenhong Zhao et al. EXPERIMENTAL LUNG RESEARCH
- Short Communication The genetic variant rs401681C/T is associated with the risk of non-small cell lung cancer in a Chinese mainland population
- (2013) H. Wang et al. GENETICS AND MOLECULAR RESEARCH
- Genetic polymorphisms of TERT and CLPTM1L and risk of lung cancer—A case–control study in a Chinese population
- (2013) Ajay A. Myneni et al. LUNG CANCER
- Genetic Variations in TERT-CLPTM1L Genes and Risk of Lung Cancer in Chinese Women Nonsmokers
- (2013) Cheng Li et al. PLoS One
- Genetic Variant rs401681 at 5p15.33 Modifies Susceptibility to Lung Cancer but Not Esophageal Squamous Cell Carcinoma
- (2013) Man Jiang et al. PLoS One
- The SNP rs402710 in 5p15.33 Is Associated with Lung Cancer Risk: A Replication Study in Chinese Population and a Meta-Analysis
- (2013) Xuzai Lu et al. PLoS One
- GSTT1 null genotype contributes to hepatocellular carcinoma risk: a meta-analysis
- (2013) Ke-Ji Chen et al. TUMOR BIOLOGY
- Quantitative assessment of the influence of common variations on 6p21 and lung cancer risk
- (2013) Jicheng TanTai et al. TUMOR BIOLOGY
- Multiple variants of TERT and CLPTM1L constitute risk factors for lung adenocarcinoma
- (2012) X.F. Chen et al. GENETICS AND MOLECULAR RESEARCH
- Association between a Genome-Wide Association Study-Identified Locus and the Risk of Lung Cancer in Japanese Population
- (2012) Hidemi Ito et al. Journal of Thoracic Oncology
- Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia
- (2012) Qing Lan et al. NATURE GENETICS
- A genome-wide association study identifies two new susceptibility loci for lung adenocarcinoma in the Japanese population
- (2012) Kouya Shiraishi et al. NATURE GENETICS
- Functional Characterization of CLPTM1L as a Lung Cancer Risk Candidate Gene in the 5p15.33 Locus
- (2012) Michael A. James et al. PLoS One
- Replication of results of genome-wide association studies on lung cancer susceptibility loci in a Korean population
- (2012) EUN YOUNG BAE et al. RESPIROLOGY
- Novel genetic variants in the chromosome 5p15.33 region associate with lung cancer risk
- (2011) Mala Pande et al. CARCINOGENESIS
- A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese
- (2011) Zhibin Hu et al. NATURE GENETICS
- Individual and Cumulative Effects of GWAS Susceptibility Loci in Lung Cancer: Associations after Sub-Phenotyping for COPD
- (2011) Robert P. Young et al. PLoS One
- Smoking Related Cancers and Loci at Chromosomes 15q25, 5p15, 6p22.1 and 6p21.33 in the Polish Population
- (2011) Ewa Jaworowska et al. PLoS One
- A Rigorous and Comprehensive Validation: Common Genetic Variations and Lung Cancer
- (2010) P. Yang et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- A genome-wide association study reveals susceptibility variants for non-small cell lung cancer in the Korean population
- (2010) Kyong-Ah Yoon et al. HUMAN MOLECULAR GENETICS
- Replication of Lung Cancer Susceptibility Loci at Chromosomes 15q25, 5p15, and 6p21: A Pooled Analysis From the International Lung Cancer Consortium
- (2010) Therese Truong et al. JNCI-Journal of the National Cancer Institute
- Variation in TP63 is associated with lung adenocarcinoma susceptibility in Japanese and Korean populations
- (2010) Daiki Miki et al. NATURE GENETICS
- The 5p15.33 Locus Is Associated with Risk of Lung Adenocarcinoma in Never-Smoking Females in Asia
- (2010) Chao Agnes Hsiung et al. PLoS Genetics
- A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma
- (2009) Maria Teresa Landi et al. AMERICAN JOURNAL OF HUMAN GENETICS
- The TERT-CLPTM1L lung cancer susceptibility variant associates with higher DNA adduct formation in the lung
- (2009) S. Zienolddiny et al. CARCINOGENESIS
- Common genetic variants on 5p15.33 contribute to risk of lung adenocarcinoma in a Chinese population
- (2009) Guangfu Jin et al. CARCINOGENESIS
- Family history of cancer and nonmalignant lung diseases as risk factors for lung cancer
- (2009) Ying Gao et al. INTERNATIONAL JOURNAL OF CANCER
- Sequence variants at the TERT-CLPTM1L locus associate with many cancer types
- (2009) Thorunn Rafnar et al. NATURE GENETICS
- A variant associated with nicotine dependence, lung cancer and peripheral arterial disease
- (2008) Thorgeir E. Thorgeirsson et al. NATURE
- A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25
- (2008) Rayjean J. Hung et al. NATURE
- Common 5p15.33 and 6p21.33 variants influence lung cancer risk
- (2008) Yufei Wang et al. NATURE GENETICS
- Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1
- (2008) Christopher I Amos et al. NATURE GENETICS
- Lung cancer susceptibility locus at 5p15.33
- (2008) James D McKay et al. NATURE GENETICS
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started